By Kate Holton, Andrew MacAskill and Elizabeth Piper LONDON, Jan 23 (Reuters) - British finance minister Rachel Reeves will ...

AstraZeneca Canada is pleased to announce that Tagrisso® (osimertinib) and Calquence® (acalabrutinib tablets) are now publicly funded in Ontario and are among the first therapies to receive ...

Daiichi Sankyo and AstraZeneca’s Enhertu has received approval from China’s NMPA for adult patients with locally advanced or ...

LLY's oncology drugs, led by Verzenio and new launches, are set to support upcoming Q4 results as investor focus broadens ...

A U.S. appeals court on Friday reinstated a lawsuit claiming some of the world’s largest drug and medical‑device companies ...

This symposium took place during the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin, Germany. The aim ...

Delays in transferring patients with stroke for advanced treatment are linked to worse disability, fewer lifesaving procedures, and more complications, a large US study shows.

Daiichi Sankyo & AstraZeneca’s Enhertu approved in China as first and only HER2 directed ADC for second-line treatment of patients with HER2 positive metastatic gastric cancer ...

The fact that New York Attorney General Letitia James, a state enforcer, brought the insider trading case was alarming for ...

The panel discussion, “Innovations in Breast Cancer Treatment,” examined the challenge of maintaining or increasing access to care as breast cancer treatment becomes more stratified through biomarker ...

ACON Laboratories, Inc. today announced the retail availability of the first FDA-cleared home test which allows families to ...